查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1592932

失眠藥物治療市場：按藥物、治療方法、分銷管道分類 - 全球預測 2025-2030

Insomnia Pharmacological Treatment Market by Drug (OTC Drugs, OTC Sleep Aids, OTC Sleep Supplements), Treatment (Over-the-Counter Sleep Aids, Prescription Sleep Aids), Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年失眠藥物治療市場價值為65.8億美元，預計到2024年將達到70.1億美元，複合年成長率為7.07%，到2030年將達到106.2億美元，預計將達到1000萬美元。

失眠的藥物治療範圍主要包括用於治療失眠的處方藥和非處方藥，失眠的特徵是難以入睡或維持睡眠。由於失眠症發生率很高，這些治療是必要的，失眠會對身心健康產生負面影響並降低生活品質。它們的應用涵蓋各種最終用途，包括醫院、診所和零售藥局，這些地方通常由成年人使用，並且越來越多的老年人使用它們。影響市場的主要成長要素包括壓力水平上升、老年人口增加、心理健康意識提高以及副作用更少的藥物治療的進步。此外，協助患者管理的數位健康工具的出現為提高治療的有效性和客製化提供了潛在的機會。開發具有獨特作用機制且成癮性較低的藥物以及使用人工智慧的個人化醫療方法的機會比比皆是。然而，市場成長面臨一些限制，例如長期藥物的副作用、監管挑戰以及認知行為療法等替代非藥物治療。此外，某些失眠藥物濫用和依賴的可能性也是一個迫切的問題。該領域的創新圍繞著開發更安全、不成癮的選擇，並利用生物技術來開發更好地針對特定神經傳導物質的藥物。了解失眠相關疾病複雜性的研究為突破提供了肥沃的土壤。該市場的特點是充滿活力和競爭格局，老牌大型製藥企業和新興生物技術企業在新療法研究方面處於領先地位。與數位健康平台的合作也標誌著整體失眠管理的重要趨勢，凸顯了醫療和技術進步之間的協同效應。瞄準市場領先地位的公司應優先考慮針對這些新興科技趨勢的研發投資，同時有效應對監管和臨床實驗狀況。

主要市場統計
基準年[2023] 65.8億美元
預測年份 [2024] 70.1億美元
預測年份 [2030] 106.2億美元
複合年成長率（%） 7.07%

市場動態：快速發展的失眠藥物治療市場的關鍵市場洞察

供需的動態交互作用正在改變失眠藥物治療市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 各種類型的睡眠障礙（包括失眠和異態睡眠）的盛行率上升
    • 與工作相關的壓力水平和殘疾急劇上升
    • 由於患者意識的提高，與失眠相關的諮詢數量不斷增加
  • 市場限制因素
    • 與某些非處方藥和處方藥相關的副作用
  • 市場機會
    • 透過高效率的研發活動開發新產品
    • 改善睡眠品質的非藥物治療的進展
  • 市場挑戰
    • 有些患者對失眠存在個別層面的恥辱

波特五力：開拓失眠藥物治療市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解失眠藥物治療市場的外部影響

外部宏觀環境因素在塑造失眠藥物治療市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解失眠藥物治療市場的競爭格局

對失眠藥物治療市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣失眠藥物治療市場供應商的績效評估

FPNV 定位矩陣是評估失眠藥物治療市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議為失眠藥物治療市場制定成功之路

對於旨在加強在全球市場的影響力的公司來說，對失眠藥物治療市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 失眠、睡眠障礙等各種睡眠障礙的盛行率不斷增加。
      • 與工作相關的壓力水平和殘疾急劇上升
      • 由於患者意識的提高，與失眠相關的醫師諮詢量不斷增加
    • 抑制因素
      • 與某些非處方藥和處方藥相關的副作用
    • 機會
      • 透過高效率的研發活動開發新產品
      • 改善睡眠品質的非藥物治療的進展
    • 任務
      • 有些患者對失眠存在個別層面的恥辱
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 失眠藥物治療市場（依藥物）

  • 非處方藥
  • 非處方安眠藥
  • 非處方睡眠補充品
  • 處方藥

第7章依治療方式分類的失眠藥物治療市場

  • 非處方安眠藥
    • 抗組織胺藥
    • 褪黑素
    • 纈草根
  • 處方助眠藥
    • 苯二氮平類
    • 褪黑激素受體拮抗劑
    • 非苯二氮平類藥物
      • Eszopiclone
      • Zaleplon
      • Zolpidem
    • Orexin拮抗劑

第8章失眠藥物治療市場：按通路

  • 藥局
  • 電子商務
  • 醫院藥房
  • 零售藥房

第9章北美與南美失眠藥物治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太失眠藥物治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲失眠藥物治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Aa Pharma Inc.
  • Amneal Pharmaceuticals LLC
  • BlaQmax by Akay Natural Ingredients Private Limited
  • Dr. Reddy's Laboratories
  • Eisai Co., Ltd.
  • Fresenius Kabi AG
  • Gemini Pharmaceuticals
  • Idorsia Pharmaceuticals Ltd.
  • Ingenus Pharmaceuticals
  • Makers Nutrition, LLC
  • Merck & Co., Inc.
  • Micro Labs Limited
  • Paratek Pharmaceuticals, Inc.
  • Pfizer Inc.
  • Purdue Pharma LP
  • Sanofi SA
  • Sivem Pharmaceuticals ULC
  • Sleepme Inc.
  • SMP Nutra
  • Sumitomo Pharma Co., Ltd.
  • Takeda Pharmaceuticals Company Ltd.
  • TriVue Pharmaceuticals, Inc.
  • Tru Body Wellness
  • Vanda Pharmaceuticals
  • Vera Herbals LLC
  • Viatris Inc.
Product Code: MRR-FB6C9E792FEB

The Insomnia Pharmacological Treatment Market was valued at USD 6.58 billion in 2023, expected to reach USD 7.01 billion in 2024, and is projected to grow at a CAGR of 7.07%, to USD 10.62 billion by 2030.

The scope of insomnia pharmacological treatment primarily includes prescription and over-the-counter medications used to manage sleeplessness, characterized by difficulty in falling asleep or maintaining sleep. These treatments are necessary due to the high prevalence of insomnia, which can adversely affect mental and physical health and diminish the quality of life. Their application spans various end-users, including hospitals, clinics, and retail pharmacies, often used by adults and increasingly by the elderly population. Key growth factors influencing the market include rising stress levels, a growing geriatric populace, increasing awareness about mental health, and advances in medication with fewer side effects. Moreover, the advent of digital health tools that assist in patient management presents a potential opportunity for enhancing treatment efficacy and customization. Opportunities abound in developing medications with unique mechanisms of action and fewer dependencies, as well as leveraging AI for personalized medicine approaches. However, the market growth faces limitations from the side effects of long-term medication use, regulatory challenges, and alternative non-pharmacological treatments like cognitive behavioral therapy. Furthermore, the potential for abuse or dependency on some insomnia medications is a pressing concern. Innovation in this area revolves around developing safer, non-habit-forming options and leveraging biotechnology to create drugs that target specific neurotransmitters better. Research into understanding the complexities of insomnia-associated disorders offers fertile ground for breakthroughs. The market is characterized by a dynamic and competitive landscape with both established pharmaceutical giants and emerging biotech startups leading research in novel therapeutics. Cooperation with digital health platforms also signals a significant trend towards holistic insomnia management, highlighting the synergy between medical treatment and technological advancement. Companies aiming for market leadership should prioritize R&D investments focused on these emerging scientific and technological trends while navigating through the regulatory and clinical trial landscape effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 6.58 billion
Estimated Year [2024] USD 7.01 billion
Forecast Year [2030] USD 10.62 billion
CAGR (%) 7.07%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Insomnia Pharmacological Treatment Market

The Insomnia Pharmacological Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of different types of sleep disorders including insomnia and parasomnias
    • Surge in work related stress level and physical disorders
    • Increasing visits to doctor regarding to insomnia owing to rising awareness among patients
  • Market Restraints
    • Side effects associated with certain OTC and prescription medication
  • Market Opportunities
    • Development of novel products through efficient R&D activities
    • Advancement in non-pharmacological therapy to improve sleep quality
  • Market Challenges
    • Individual level stigma about insomnia in some patients

Porter's Five Forces: A Strategic Tool for Navigating the Insomnia Pharmacological Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Insomnia Pharmacological Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Insomnia Pharmacological Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Insomnia Pharmacological Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Insomnia Pharmacological Treatment Market

A detailed market share analysis in the Insomnia Pharmacological Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Insomnia Pharmacological Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Insomnia Pharmacological Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Insomnia Pharmacological Treatment Market

A strategic analysis of the Insomnia Pharmacological Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Insomnia Pharmacological Treatment Market, highlighting leading vendors and their innovative profiles. These include Aa Pharma Inc., Amneal Pharmaceuticals LLC, BlaQmax by Akay Natural Ingredients Private Limited, Dr. Reddy's Laboratories, Eisai Co., Ltd., Fresenius Kabi AG, Gemini Pharmaceuticals, Idorsia Pharmaceuticals Ltd., Ingenus Pharmaceuticals, Makers Nutrition, LLC, Merck & Co., Inc., Micro Labs Limited, Paratek Pharmaceuticals, Inc., Pfizer Inc., Purdue Pharma L.P., Sanofi S.A., Sivem Pharmaceuticals ULC, Sleepme Inc., SMP Nutra, Sumitomo Pharma Co., Ltd., Takeda Pharmaceuticals Company Ltd., TriVue Pharmaceuticals, Inc., Tru Body Wellness, Vanda Pharmaceuticals, Vera Herbals LLC, and Viatris Inc..

Market Segmentation & Coverage

This research report categorizes the Insomnia Pharmacological Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Drug, market is studied across OTC Drugs, OTC Sleep Aids, OTC Sleep Supplements, and Prescription Drugs.
  • Based on Treatment, market is studied across Over-the-Counter Sleep Aids and Prescription Sleep Aids. The Over-the-Counter Sleep Aids is further studied across Antihistamines, Melatonin, and Valerian Roots. The Prescription Sleep Aids is further studied across Benzodiazepines, Melatonin Receptor Antagonists, Non-benzodiazepines, and Orexin Antagonists. The Non-benzodiazepines is further studied across Eszopiclone, Zaleplon, and Zolpidem.
  • Based on Distribution Channel, market is studied across Drug Stores, E-Commerce, Hospital Pharmacies, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of different types of sleep disorders including insomnia and parasomnias
      • 5.1.1.2. Surge in work related stress level and physical disorders
      • 5.1.1.3. Increasing visits to doctor regarding to insomnia owing to rising awareness among patients
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects associated with certain OTC and prescription medication
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of novel products through efficient R&D activities
      • 5.1.3.2. Advancement in non-pharmacological therapy to improve sleep quality
    • 5.1.4. Challenges
      • 5.1.4.1. Individual level stigma about insomnia in some patients
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Insomnia Pharmacological Treatment Market, by Drug

  • 6.1. Introduction
  • 6.2. OTC Drugs
  • 6.3. OTC Sleep Aids
  • 6.4. OTC Sleep Supplements
  • 6.5. Prescription Drugs

7. Insomnia Pharmacological Treatment Market, by Treatment

  • 7.1. Introduction
  • 7.2. Over-the-Counter Sleep Aids
    • 7.2.1. Antihistamines
    • 7.2.2. Melatonin
    • 7.2.3. Valerian Roots
  • 7.3. Prescription Sleep Aids
    • 7.3.1. Benzodiazepines
    • 7.3.2. Melatonin Receptor Antagonists
    • 7.3.3. Non-benzodiazepines
      • 7.3.3.1. Eszopiclone
      • 7.3.3.2. Zaleplon
      • 7.3.3.3. Zolpidem
    • 7.3.4. Orexin Antagonists

8. Insomnia Pharmacological Treatment Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Drug Stores
  • 8.3. E-Commerce
  • 8.4. Hospital Pharmacies
  • 8.5. Retail Pharmacies

9. Americas Insomnia Pharmacological Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Insomnia Pharmacological Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Insomnia Pharmacological Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aa Pharma Inc.
  • 2. Amneal Pharmaceuticals LLC
  • 3. BlaQmax by Akay Natural Ingredients Private Limited
  • 4. Dr. Reddy's Laboratories
  • 5. Eisai Co., Ltd.
  • 6. Fresenius Kabi AG
  • 7. Gemini Pharmaceuticals
  • 8. Idorsia Pharmaceuticals Ltd.
  • 9. Ingenus Pharmaceuticals
  • 10. Makers Nutrition, LLC
  • 11. Merck & Co., Inc.
  • 12. Micro Labs Limited
  • 13. Paratek Pharmaceuticals, Inc.
  • 14. Pfizer Inc.
  • 15. Purdue Pharma L.P.
  • 16. Sanofi S.A.
  • 17. Sivem Pharmaceuticals ULC
  • 18. Sleepme Inc.
  • 19. SMP Nutra
  • 20. Sumitomo Pharma Co., Ltd.
  • 21. Takeda Pharmaceuticals Company Ltd.
  • 22. TriVue Pharmaceuticals, Inc.
  • 23. Tru Body Wellness
  • 24. Vanda Pharmaceuticals
  • 25. Vera Herbals LLC
  • 26. Viatris Inc.

LIST OF FIGURES

  • FIGURE 1. INSOMNIA PHARMACOLOGICAL TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. INSOMNIA PHARMACOLOGICAL TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INSOMNIA PHARMACOLOGICAL TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OTC DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OTC SLEEP AIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OTC SLEEP SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY MELATONIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY VALERIAN ROOTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY BENZODIAZEPINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY MELATONIN RECEPTOR ANTAGONISTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ESZOPICLONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ZALEPLON, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ZOLPIDEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OREXIN ANTAGONISTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 283. INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 284. INSOMNIA PHARMACOLOGICAL TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023